Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

154.58
-0.3500-0.23%
Post-market: 153.90-0.6801-0.44%19:57 EDT
Volume:8.64M
Turnover:1.33B
Market Cap:371.93B
PE:17.20
High:154.90
Open:154.32
Low:152.45
Close:154.93
Loading ...

the New Sites and Extensions Will Be Built Over Five Years and Are Expected to Create More Than 4,000 Jobs

THOMSON REUTERS
·
11 Apr

BofA Adjusts Price Target on Johnson & Johnson to $159 From $171, Keeps Buy Rating

MT Newswires Live
·
10 Apr

BRIEF-Icotrokinra Results Show 75% Of Adolescents With Plaque Psoriasis Achieved Clear Skin

Reuters
·
10 Apr

Jim Cramer’s Take On Johnson & Johnson (JNJ): Are Litigation Fears Creating a Rare Buying Opportunity?

Insider Monkey
·
10 Apr

Johnson & Johnson Is Maintained at Neutral by B of A Securities

Dow Jones
·
10 Apr

Icotrokinra Results Show 75% of Adolescents With Plaque Psoriasis Achieved Completely Clear Skin and Demonstrate Favorable Safety Profile in a Once Daily Pill

THOMSON REUTERS
·
10 Apr

Johnson & Johnson - Icotrokinra Shows Favorable Safety Profile With 50% Experiencing ≥1 Ae

THOMSON REUTERS
·
10 Apr

Johnson & Johnson - 84% of Adolescents Achieved Clear or Almost Clear Skin at Week 16

THOMSON REUTERS
·
10 Apr

Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin and demonstrate favorable safety profile in a once daily pill

PR Newswire
·
10 Apr

J&J : Bofa Global Research Cuts Price Objective to $159 From $171

THOMSON REUTERS
·
10 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
10 Apr

The Dow Crashed 4,260 Points in 3 Days: Here Are 3 Dow Stocks That Make for No-Brainer Buys Right Now

Motley Fool
·
10 Apr

Consumer Brands, Utilities Miss Out on Rally Following Tariff Pause -- Market Talk

Dow Jones
·
10 Apr

Johnson & Johnson (NYSE:JNJ) Shares React as FDA Grants Multiple Designations to Nipocalimab

Simply Wall St.
·
10 Apr

Why drug stocks are no longer a safe haven from the stock market's turmoil

Dow Jones
·
09 Apr

Amgen, Merck Share Losses Contribute To Dow's 262-Point Drop

Dow Jones
·
09 Apr

Major Pharma Stocks Down Amid Tariff Turmoil

MT Newswires Live
·
09 Apr

Merck, Goldman Sachs Share Losses Lead Dow's 166-Point Fall

Dow Jones
·
09 Apr

Shares of Drugmakers Down After Trump Threatens Tariffs on Sector

THOMSON REUTERS
·
09 Apr

Halozyme Says European Commission Approves Darzalex Co-Formulated With Enhanze to Treat Multiple Myeloma

MT Newswires Live
·
09 Apr